Class I - Dangerous
Marketed without an approved NDA/ANDA: Undeclared sibutramine.
Marketed without an approved NDA/ANDA: Undeclared sibutramine.
Marketed without an approved NDA/ANDA: Undeclared sibutramine.
Marketed without an approved NDA/ANDA: Undeclared sibutramine.